Pharmacists worried about impact of AMP rule
More than a quarter of pharmacists say they will be forced to close their pharmacies if CMS enacts a proposed rule to base reimbursement for Medicaid generic drugs on the average manufacturers price (AMP), according to an on-line poll at drugtopics.com. Another 25% of the 271 pharmacists who participated in the poll responded that they would push for higher dispensing fees in their state. Others responded that if the rule is enacted as it was proposed, it could force them to change how they participate in Medicaid, with 18% pledging that they would no longer participate in the program, 12% vowing they would switch patients from generic to brand drugs, and 11% suggesting they would stop dispensing generic drugs for Medicaid patients. Only 8% of respondents indicated that it would have no impact on their pharmacy.
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
How Mark Cuban Cost Plus Drug Company Is Approaching Drug Pricing Transparency
October 14th 2024Erin Albert, vice president of pharmacy relations and chief privacy officer at Mark Cuban Cost Plus Drug Company, PBC, discussed drug pricing and what her company is doing to revolutionize transparency.
